Press

ATMA Welcomes Dr. Scott Shannon, MAPS MDMA Phase 3 Principal Investigator, to Expand Its’ Clinical Training Expertise in MDMA-Assisted Therapy

Oct 25 • 5 min read

Dr. Shannon will provide valuable expertise towards MDMA-Assisted Therapy Training from a MAPS clinical protocols foundation. ATMA Journey Centers Inc. (“ATMA”), a Canadian company with a primary focus on advancing psychedelic-assisted therapy, is pleased to announce its collaboration with Dr. Scott Shannon to prepare practitioners in training for the eagerly anticipated legalization of MDMA for MDMA-assisted therapy…

First Patient Dosed in Beckley Psytech’s International Phase IIb Study of BPL-003, a Novel Synthetic Intranasal Formulation of 5-MeO-DMT, for Treatment Resistant Depression (TRD)

Oct 25 • 4 min read

Beckley Psytech Ltd, a private, clinical-stage biotechnology company developing rapid-acting, short-duration psychedelic medicines for neuropsychiatric conditions, confirmed today that the first patient had been dosed in its multi-site Phase IIb study (NCT05870540) of BPL-003, a novel synthetic formulation of 5-MeO-DMT (also known as Mebufotenin), for Treatment Resistant Depression (TRD). The study is taking place at…

The Healing Company’s Chopra and Swan Hellenic Announce Exclusive, Multi-Year Partnership With Launch of Well-Being Travel Experience “Explore & Restore”

Oct 25 • 7 min read

Chopra and Swan Hellenic “Explore & Restore” Well-Being Voyage Chopra, a leading integrative health company founded by global well-being pioneer Dr. Deepak Chopra, M.D. and part of The Healing Company Inc. (OTCQB: HLCO) (“The Healing Company” or the “Company”), today announced an exclusive, multi-year partnership with Swan Hellenic, a leader in luxury cultural expeditions by sea. Inspired by…

Cybin Announces Grant of Two New United States Patents Protecting its Deuterated DMT Program

Oct 25 • 3 min read

–New United States patent grants offer protection for deuterated analogs of DMT including composition of matter, medical use and synthesis – – Intellectual Property portfolio provides robust protection for most extensive deuterated DMT portfolio in the sector – – Cybin’s Intellectual Property portfolio now consists of 32granted patents and over 170 pending applications – Cybin…

Colorado DOR Natural Medicine Division Listening Sessions: Part 1

Oct 25 • 15 min read

One of the most significant structural changes SB23-290 made to the original Natural Medicine Health Act was the creation of the Natural Medicine Division (“NMD”) within the Colorado Department of Revenue (“DOR”). While the training and licensing of Facilitators remains within the purview of the Division of Professions and Occupations within DORA, the newly-created NMD…

Pages: 123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435